BAFF/APRIL Responsive BCMA-NF-kappaB Luciferase Reporter HEK293 Cell Line

Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-79755 2 vials - -

3 - 15 business days*

13,779.00€
 
The BCMA / NF-kappaB - HEK293 recombinant cell line has been transfected with full-length human... more
Product information "BAFF/APRIL Responsive BCMA-NF-kappaB Luciferase Reporter HEK293 Cell Line"
The BCMA / NF-kappaB - HEK293 recombinant cell line has been transfected with full-length human BCMA cDNA (Genbank #NM_001192) under control of a CMV promoter for high constitutive expression. The NF-kappaB-luciferase reporter is also stably integrated into the genome. The firefly luciferase gene is controlled by four copies of the NF-kappaB Response Element upstream of a minimal promoter. Upon ligand binding, active BCMA will initiate the NF-kappaB signaling pathway, leading to expression of the NF-kappaB-controlled luciferase reporter.
Keywords: tumor necrosis factor receptor superfamily member 17, B-Cell Maturation Antigen, TNFRSF17, CD269,
Supplier: BPS Bioscience
Supplier-Nr: 79755

Properties

Application: CAR T-cell therapy research
Species reactivity: human

Handling & Safety

Storage: -80°C (store in liquid nitrogen)
Shipping: -80°C (International: °C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "BAFF/APRIL Responsive BCMA-NF-kappaB Luciferase Reporter HEK293 Cell Line"
Write a review
or to review a product.
Viewed